View in EDS PDF Full Text

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

Saved in:
Bibliographic Details
Title: Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.
Authors: Ogura Y; Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Science, Nagoya, Japan. Electronic address: ogura@med.nagoya-cu.ac.jp., Roider J; Department of Ophthalmology, University of Kiel, Kiel, Germany., Korobelnik JF; Service d'ophtalmologie, Hopital Pellegrin-CHU de Bordeaux, Bordeaux, France; Université Bordeaux Segalen, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France., Holz FG; Department of Ophthalmology, University of Bonn, Bonn, Germany., Simader C; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria., Schmidt-Erfurth U; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria., Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Berliner AJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Hiemeyer F; Bayer HealthCare AG, Berlin, Germany., Stemper B; Bayer HealthCare AG, Berlin, Germany; Department of Neurology, University of Erlangen-Nürnberg, Germany., Zeitz O; Bayer HealthCare AG, Berlin, Germany; Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Sandbrink R; Bayer HealthCare AG, Berlin, Germany; Department of Neurology, Heinrich-Heine-Universität, Düsseldorf, Germany.
Corporate Authors: GALILEO Study Group
Source: American journal of ophthalmology [Am J Ophthalmol] 2014 Nov; Vol. 158 (5), pp. 1032-8. Date of Electronic Publication: 2014 Jul 25.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25068637
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ogura+Y%22">Ogura Y</searchLink>; Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Science, Nagoya, Japan. Electronic address: ogura@med.nagoya-cu.ac.jp.<br /><searchLink fieldCode="AU" term="%22Roider+J%22">Roider J</searchLink>; Department of Ophthalmology, University of Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Korobelnik+JF%22">Korobelnik JF</searchLink>; Service d'ophtalmologie, Hopital Pellegrin-CHU de Bordeaux, Bordeaux, France; Université Bordeaux Segalen, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Holz+FG%22">Holz FG</searchLink>; Department of Ophthalmology, University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Simader+C%22">Simader C</searchLink>; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schmidt-Erfurth+U%22">Schmidt-Erfurth U</searchLink>; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Vitti+R%22">Vitti R</searchLink>; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Berliner+AJ%22">Berliner AJ</searchLink>; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Hiemeyer+F%22">Hiemeyer F</searchLink>; Bayer HealthCare AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Stemper+B%22">Stemper B</searchLink>; Bayer HealthCare AG, Berlin, Germany; Department of Neurology, University of Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Zeitz+O%22">Zeitz O</searchLink>; Bayer HealthCare AG, Berlin, Germany; Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Sandbrink+R%22">Sandbrink R</searchLink>; Bayer HealthCare AG, Berlin, Germany; Department of Neurology, Heinrich-Heine-Universität, Düsseldorf, Germany.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22GALILEO+Study+Group%22">GALILEO Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370500%22">American journal of ophthalmology</searchLink> [Am J Ophthalmol] 2014 Nov; Vol. 158 (5), pp. 1032-8. <i>Date of Electronic Publication: </i>2014 Jul 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-1891 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200029394%22">00029394 </searchLink><i>NLM ISO Abbreviation: </i>Am J Ophthalmol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25068637
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ajo.2014.07.027
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1032
    Titles:
      – TitleFull: Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ogura Y
      – PersonEntity:
          Name:
            NameFull: Roider J
      – PersonEntity:
          Name:
            NameFull: Korobelnik JF
      – PersonEntity:
          Name:
            NameFull: Holz FG
      – PersonEntity:
          Name:
            NameFull: Simader C
      – PersonEntity:
          Name:
            NameFull: Schmidt-Erfurth U
      – PersonEntity:
          Name:
            NameFull: Vitti R
      – PersonEntity:
          Name:
            NameFull: Berliner AJ
      – PersonEntity:
          Name:
            NameFull: Hiemeyer F
      – PersonEntity:
          Name:
            NameFull: Stemper B
      – PersonEntity:
          Name:
            NameFull: Zeitz O
      – PersonEntity:
          Name:
            NameFull: Sandbrink R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2014 Nov
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1879-1891
          Numbering:
            – Type: volume
              Value: 158
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: American journal of ophthalmology
              Type: main
ResultId 1